Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?

Area of Science:

• Gastroenterology
• Infectious Diseases
• Pharmacology

Background:

• Pretreatment with omeprazole may affect Helicobacter pylori eradication efficacy.
• Understanding optimal timing of antibiotics with proton pump inhibitors is crucial for treatment success.

Purpose of the Study:

• To compare the efficacy, safety, and tolerability of a triple therapy regimen (omeprazole/amoxicillin/metronidazole) for H. pylori eradication.
• To investigate if administering antibiotics during the first or last two weeks of omeprazole therapy influences outcomes.

Main Methods:

• A prospective, controlled study involving 78 symptomatic peptic ulcer patients.
• Patients received 4 weeks of omeprazole (40 mg daily) with amoxicillin and metronidazole administered during either the first or last 2 weeks.
• H. pylori status was assessed using culture, histology, urease test, and IgG antibodies, with a 1-year follow-up.

Main Results:

• H. pylori eradication rates were high in both groups: 97.4% (group A) and 89% (group B), with no statistically significant difference (p=0.28).
• Peptic ulcer healing rates reached 100% in both groups, with similar symptom relief.
• Both regimens were well-tolerated, with comparable minor side-effect rates (40% vs. 38%) and no treatment withdrawals.

Conclusions:

• Omeprazole pretreatment does not significantly reduce the efficacy of H. pylori eradication therapy in peptic ulcer patients.
• The timing of antibiotic administration (early vs. late in omeprazole therapy) did not impact eradication rates, ulcer healing, or tolerability.